Illumina constellation technology identifies hard-to-detect genetic variants

Go back to Illumina constellation technology identifies hard-to-detect genetic variants

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

October 15, 2025 9:15 AM UTC

Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx

Constellation outperformed orthogonal methods in identifying select difficult-to-map variants

SAN DIEGO, Oct. 15, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that GeneDx, a leader in genetic testing for rare diseases, is piloting... More